GHK-CU Strengths and Limitations For detailed GHK-CU dosing information , the standard approach involves 1-2mg daily for injectable protocols or 2-4% concentration for topical applications
Timing considerations AOD 9604 works best when injected in a fasted state
The study comprised a single intravenous (i.v.) administration of the peptide (20 g/kg in Sprague-Dawley rats and 6 g/kg in beagle dogs), a single intramuscular (i.m.) administration of 20, 100, or 500 g/kg (rats) and 6, 30, or 150 g/kg (dogs), and repeated i.m
2025 Dec;18(12):611-619
Well walk you through: what its designed for, what to expect, what a protocol looks like, and whether its appropriate for your goals
Tissue Repair Compound Research blend of BPC-157 (15-mer gastric pentadecapeptide) and TB-500 (thymosin -4 actin-binding fragment) for comparative tissue-pathway studies in vitro